BrightInsightThe best-in-class BrightInsight Platform accelerates the time to market for patient apps that enable biopharma companies to differentiate their therapies and enhance the patient journeySAN JOSE, Calif., May 23, 2023 (GLOBE NEWSWIRE) — BrightInsight, Inc., provider of the leading…
Source: finance.yahoo.com – Read more
Court Grants Vizgen Motion to Expand Antitrust Case vs.10x, Harvard
A US District Court judge has permitted Vizgen to expand its antitrust lawsuit against 10x Genomics and Harvard University, with new evidence implicating potential attempts